calcium dobesilate has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, S; Liu, C; Sun, D; Wang, N; Wang, Y; Zuo, B | 1 |
| Bu, X; Li, X; Su, J; Wang, F; Wei, D; Yan, F; Yuan, J; Zheng, W | 1 |
2 other study(ies) available for calcium dobesilate and Cirrhosis
| Article | Year |
|---|---|
Calcium dobesilate mediates renal interstitial fibrosis and delay renal peritubular capillary loss through Sirt1/p53 signaling pathway.
Topics: Animals; Apoptosis; Calcium Dobesilate; Capillaries; Disease Models, Animal; Disease Progression; Fibrosis; Hemostatics; Human Umbilical Vein Endothelial Cells; Humans; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Sirtuin 1; Tumor Suppressor Protein p53 | 2020 |
Deletion of discoidin domain receptor 2 attenuates renal interstitial fibrosis in a murine unilateral ureteral obstruction model.
Topics: Administration, Oral; Animals; Calcium Dobesilate; Discoidin Domain Receptor 2; Disease Models, Animal; Disease Progression; Fibrosis; Humans; Kidney Tubules; Mice; Mice, Transgenic; Renal Insufficiency, Chronic; Sequence Deletion; Severity of Illness Index; Ureteral Obstruction | 2019 |